The "atheroprotective" mediators apolipoproteinA-I and Foxp3 are over-abundant in unstable carotid plaques

International Journal of Cardiology

Volumn 145, Issue 2, 2010, Pages 183-187

  Patel, S ^a,b   Chung, S H ^b   White, G ^a,b   Bao, S ^b   Celermajer, D S ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

ApolipoproteinA I; Atherosclerosis; Foxp3; Inflammation; T cells

Indexed keywords

APOLIPOPROTEIN A1; CD3 ANTIGEN; CD68 ANTIGEN; GELATINASE A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 17; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; TRANSCRIPTION FACTOR FOXP3; TRIACYLGLYCEROL; APOA1 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COLOR ULTRASOUND FLOWMETRY; COMORBIDITY; COMPUTER PROGRAM; CONTROLLED STUDY; DIGITAL IMAGING; ENDARTERECTOMY; FEMALE; HEART PROTECTION; HUMAN; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE; ATHEROSCLEROSIS; BIOSYNTHESIS; CAROTID ARTERY OBSTRUCTION; COMPARATIVE STUDY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AGED; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; CAROTID STENOSIS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE;

EID: 78650025765     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.05.024     Document Type: Article

References (32)

1. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
2. S. Patel, D.S. Celermajer, and S. Bao Atherosclerosis-underlying inflammatory mechanisms and clinical implications Int J Biochem Cell Biol 40 2008 576 580
3. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
4. E. Falk, P.K. Shah, and V. Fuster Coronary plaque disruption Circulation 92 1995 657 671
5. G.K. Hansson, and P. Libby The immune response in atherosclerosis: a double-edged sword Nat Rev Immunol 6 2006 508 519
6. S. Jander, M. Sitzer, and R. Schumann Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization Stroke 29 1998 1625 1630
7. E. Ingelsson, E.J. Schaefer, and J.H. Contois Clinical utility of different lipid measures for prediction of coronary heart disease in men and women JAMA 298 2007 776 785
8. S.J. Nicholls, G.J. Dusting, and B. Cutri Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits Circulation 111 2005 1543 1550
9. S.J. Nicholls, K.A. Rye, and P.J. Barter High-density lipoproteins as therapeutic targets Curr Opin Lipidol 16 2005 345 349
10. J. Golledge, R. Cuming, M. Ellis, A.H. Davies, and R.M. Greenhalgh Carotid plaque characteristics and presenting symptom Br J Surg 84 1997 1697 1701
11. H. Ait-Oufella, B.L. Salomon, and S. Potteaux Natural regulatory T cells control the development of atherosclerosis in mice Nat Med 12 2006 178 180 (Pubitemid 43214743)
12. H.J. Barnett, D.W. Taylor, and M. Eliasziw Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American symptomatic carotid endarterectomy trial collaborators. [see comment] N Engl J Med 339 1998 1415 1425
13. J.F. Toole ACAS recommendations for carotid endarterectomy. ACAS executive committee. [comment] Lancet 347 1996 121
14. E.G. Grant, C.B. Benson, and G.L. Moneta Carotid artery stenosis: gray-scale and Doppler US diagnosis - Society of Radiologists in Ultrasound Consensus Conference Radiology 229 2003 340 346
15. J. Golledge, R.M. Greenhalgh, and A.H. Davies The symptomatic carotid plaque Stroke 31 2000 774 781
16. J.N. Redgrave, J.K. Lovett, P.J. Gallagher, and P.M. Rothwell Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford Plaque Study Circulation 113 2006 2320 2328
17. A. Tedgui, and Z. Mallat Cytokines in atherosclerosis: pathogenic and regulatory pathways Physiol Rev 86 2006 515 581
18. J.O. Deguchi, M. Aikawa, and C.H. Tung Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo Circulation 114 2006 55 62
19. S.J. Nicholls, and S.L. Hazen Myeloperoxidase and cardiovascular disease Arterioscler Thromb Vasc Biol 25 2005 1102 1111
20. M. Crisby, G. Nordin-Fredriksson, P.K. Shah, J. Yano, J. Zhu, and J. Nilsson Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization Circulation 103 2001 926 933
21. Z.S. Galis, G.K. Sukhova, M.W. Lark, and P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
22. P.J. Barter, S. Nicholls, K.A. Rye, G.M. Anantharamaiah, M. Navab, and A.M. Fogelman Antiinflammatory properties of HDL Circ Res 95 2004 764 772
23. C. Bergt, S. Pennathur, and X. Fu The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs abca1-dependent cholesterol transport Proc Natl Acad Sci USA 101 2004 13032 13037
24. S.J. Nicholls, L. Zheng, and S.L. Hazen Formation of dysfunctional high-density lipoprotein by myeloperoxidase Trends Cardiovasc Med 15 2005 212 219
25. R. Bacchetta, E. Gambineri, and M.G. Roncarolo Role of regulatory T cells and FOXP3 in human diseases J Allergy Clin Immunol 120 2007 227 235 quiz 236-227
26. E.A. Heller, E. Liu, and A.M. Tager Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells Circulation 113 2006 2301 2312
27. A. Mor, G. Luboshits, D. Planer, G. Keren, and J. George Altered status of CD4(+) CD25(+) regulatory T cells in patients with acute coronary syndromes Eur Heart J 27 2006 2530 2537
28. reg imbalance in patients with acute coronary syndrome Clin Immunol 127 2008 89 97
29. I.M. de Kleer, L.R. Wedderburn, and L.S. Taams CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis J Immunol 172 2004 6435 6443
30. T.T. Papas, C.K. Maltezos, and N. Papanas High-sensitivity CRP is correlated with neurologic symptoms and plaque instability in patients with severe stenosis of the carotid bifurcation Vasc Endovascular Surg 42 2008 249 255
31. B. Alvarez Garcia, C. Ruiz, P. Chacon, J.A. Sabin, and M. Matas High-sensitivity c-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque J Vasc Surg 38 2003 1018 1024
32. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150